🔗 Share this article

Texas Attorney General Paxton is suing the producers of acetaminophen, claiming the corporations concealed alleged dangers that the medication presented to pediatric brain development.

The court filing comes a month after Donald Trump advocated an unverified association between using acetaminophen - referred to as paracetamol - throughout gestation and autism in young ones.

Paxton is suing J&J, which formerly manufactured the medication, the exclusive pain medication approved for expectant mothers, and Kenvue, which presently makes it.

In a official comment, he stated they "betrayed America by gaining financially from pain and marketing drugs without regard for the risks."

The manufacturer states there is no credible evidence tying Tylenol to autism.

"These manufacturers misled for generations, knowingly endangering millions to line their pockets," Paxton, a Republican, said.

The company commented that it was "deeply concerned by the perpetuation of misinformation on the reliability of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its website, Kenvue also stated it had "regularly reviewed the applicable studies and there is lacking reliable evidence that demonstrates a proven link between taking acetaminophen and autism spectrum disorder."

Organizations speaking for medical professionals and medical practitioners share this view.

ACOG has declared acetaminophen - the key substance in Tylenol - is among limited choices for pregnant women to address discomfort and fever, which can pose significant medical dangers if ignored.

"In more than two decades of research on the utilization of paracetamol in pregnancy, zero credible investigations has definitively established that the use of acetaminophen in any stage of pregnancy results in brain development issues in offspring," the organization said.

This legal action cites latest statements from the former administration in arguing the medication is allegedly unsafe.

In recent weeks, Trump caused concern from health experts when he advised women during pregnancy to "resist strongly" not to use acetaminophen when sick.

The US Food and Drug Administration then released a statement that doctors should consider limiting the use of Tylenol, while also declaring that "a direct connection" between the drug and autism spectrum disorder in minors has remains unverified.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in spring to undertake "extensive scientific investigation" that would identify the source of autism spectrum disorder in a limited time.

But experts advised that discovering a unique factor of autism spectrum disorder - thought by researchers to be the result of a complicated interplay of genetic and external influences - would prove challenging.

Autism spectrum disorder is a form of permanent neurological difference and condition that affects how individuals perceive and relate to the world, and is recognized using doctors' observations.

In his lawsuit, the attorney general - aligned with the former president who is running for US Senate - claims Kenvue and J&J "intentionally overlooked and sought to suppress the evidence" around paracetamol and autism.

The case attempts to require the corporations "eliminate any marketing or advertising" that claims acetaminophen is reliable for women during pregnancy.

The Texas lawsuit echoes the concerns of a collection of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the manufacturers of acetaminophen in two years ago.

A federal judge rejected the case, stating investigations from the parents' expert witnesses was not conclusive.